Anas Younes, MD - NHL Cases in Point: Applying Current Evidence to Challenging Patient Scenarios
NHL Cases in Point: Applying Current Evidence to Challenging Patient Scenarios (Source: PeerView CME/CE Audio Podcast - Pathology)
Source: PeerView CME/CE Audio Podcast - Pathology - December 31, 2013 Category: Pathology Authors: Answers in CME Tags: Science, Medicine Source Type: podcasts
Finally! Data in Low-Risk HER2 Breast Cancer
Drs. Kathy Miller and Ian Krop talk about why a single-arm study in low-risk cancer is a huge advance for a population of understudied breast cancer patients. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - December 24, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
H. Jack West, MD - From Theory to Practice: Are We Prepared for the Real-Life Implications of Patient-Centered Lung Cancer Care?
(Source: PeerView CME/CE Audio Podcast - Pathology)
Source: PeerView CME/CE Audio Podcast - Pathology - December 19, 2013 Category: Pathology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
H. Jack West, MD - Challenges and Opportunities in Patient-Centered Lung Cancer Care: Where Are We Now, and Where Are We Going?
(Source: PeerView CME/CE Audio Podcast - Pathology)
Source: PeerView CME/CE Audio Podcast - Pathology - December 18, 2013 Category: Pathology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Is 'Normal' Normal in Cancer Genomics?
Dr. Maurie Markman considers how 'normal' genetic variants can influence cancer treatment outcome. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - December 3, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
Dazed and Confused About Molecular Data?
Is molecular profiling integral to choice of treatment or simply a source of confusion? Dr. John Marshall speaks to issues that need to be resolved before 'personalized medicine' is practice-ready. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - October 23, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
'Pathology' of gastric cancer
Drs. Mario Dicato and Eric Van Cutsem, along with Dr. Josep Tabernero, chaired the ESMO 15th World Congress on Gastrointestinal Cancer which was held in Barcelona, Spain, 3-6 July 2013. This webcast i...
Author: imedex
Added: 10/19/2013 (Source: Oncology Tube)
Source: Oncology Tube - October 19, 2013 Category: Cancer & Oncology Source Type: podcasts
Can the pathologist judge the quality of rectal cancer surgery and treatment?
Drs. Mario Dicato and Eric Van Cutsem, along with Dr. Josep Tabernero, chaired the ESMO 15th World Congress on Gastrointestinal Cancer which was held in Barcelona, Spain, 3-6 July 2013. This webcast i...
Author: imedex
Added: 10/10/2013 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2013 Category: Cancer & Oncology Source Type: podcasts
New ALK Agents: Lung Cancer's 'Second Miracle'?
Drs. D. Ross Camidge and Giorgio Scagliotti highlight the emerging data in ALK-positive lung cancer that will change the playing field in clinical practice. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - October 7, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
TKI Hikes Survival in Recurrent Ovarian Cancer
Cediranib, bevacizumab, and novel antiangiogenic agents continue to improve survival in first-line and recurrent ovarian cancer, as reported by Dr. Stanley Kaye from ECC 2013. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - October 4, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
The 'Darkest Year Ever' for the NIH?
American Psychiatric Association President Dr. Jeffrey Lieberman on how government policies are out of sync with our country ' s medical needs. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - October 3, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
Panitumumab: Casting a Wider Net for Improved Response
Dr. David Kerr reports on a study indicating that widening the search for RAS mutants other than exon 2 can exclude a further 17% of patients with CRC who will not benefit from panitumumab. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - October 1, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
Dr. Nielsen on the Pros and Cons of the Ki67 Assay in Breast Cancer
Torsten O. Nielsen, MD, PhD, FRCPC, a professor of pathology at the University of British Columbia, discusses the pros and cons of using the Ki67 as a prognostic marker in breast cancer.
Author: onclivetv
Added: 09/27/2013 (Source: Oncology Tube)
Source: Oncology Tube - September 27, 2013 Category: Cancer & Oncology Source Type: podcasts
